Industries
Microfluidics and Lab-on-Chip
Microfluidics and lab-on-chip technology enables precise manipulation of nanoliter-to-picoliter fluid volumes within microscale channels, dramatically reducing reagent consumption, assay time, and hands-on labor for life-science research. Leading platforms from companies such as Fluidigm, Bio-Rad Laboratories, Dolomite Microfluidics, Mimetas, and Standard BioTools power applications ranging from single-cell RNA sequencing to organ-on-a-chip disease modeling. Scientists procure chip fabrication services, syringe pumps, pressure controllers, and integrated detection modules to build bespoke assays. The technology underpins point-of-care in vitro diagnostics, digital PCR systems, droplet-based encapsulation for drug screening, and microfluidic sample preparation for next-generation sequencing. Vendors sell both commodity PDMS chips and precision glass/COC devices, as well as turnkey systems integrating electrodes, optics, and valves. Regulatory tailwinds from FDA Lab-on-Chip guidance and surging demand for decentralized diagnostics are accelerating adoption across academic cores, biotech CROs, and hospital laboratories worldwide.
Details
- Companies
- FluidigmBio-Rad LaboratoriesDolomite MicrofluidicsMimetasStandard BioToolsMicrofluidic ChipShopIllumina
- Market Size
- $8.6 billion (2024), projected $25.4 billion by 2030 at 19.7% CAGR
- Target Researchers
- Cell biologists, biomedical engineers, diagnostic scientists, single-cell biologists, drug discovery researchers, and point-of-care diagnostics developers seeking miniaturized fluid-handling platforms.
- Use Cases
- Point-of-care diagnostics on-chipSingle-cell RNA sequencing sample prepDrug screening miniaturized assaysOrgan-on-a-chip disease modelsDigital PCR droplet generationCell sorting and enrichmentProtein crystallization for structural biology